financetom
Business
financetom
/
Business
/
Why VCI Global (VCIG) Stock Is Up 90% Today
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why VCI Global (VCIG) Stock Is Up 90% Today
Nov 27, 2024 8:38 AM

VCI Global Ltd ( VCIG ) shares are trading higher by 149.2% to $4.461 during Wednesday’s session after the company announced it received a conditional letter of award valued at approximately $24 million for its proposed data center project in Enstek City, Malaysia.

What To Know: VCI Global Limited ( VCIG ) , via its subsidiary V-Gallant Sdn. Bhd., received a conditional $24 million Letter of Award from Hexatoff Group Sdn. Bhd. for a data center project in Enstek City, Malaysia. V-Gallant will supply advanced AI hardware and software to power the project’s first phase.

Hexatoff Group, a leading infrastructure solutions provider with Malaysia’s highest-grade construction license, aims to position the country as a top AI and digital infrastructure hub in Southeast Asia.

Dato’ Victor Hoo, VCI Global’s CEO, emphasized that the partnership aligns with Malaysia's vision for innovation and sustainable growth, enhancing its status as a key player in ASEAN’s digital transformation.

Read Also: Fed’s Favorite Inflation Gauge Heats Up As Predicted, Personal Incomes Soar

How To Buy VCIG Stock

Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.

For example, in VCI Global’s case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.

According to data from Benzinga Pro, VCIG has a 52-week high of $179.83 and a 52-week low of $1.38.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved